Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-09-15 02:48 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RFR Consulting, LLC (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-1,666,000 vol |
34,000 | |
Filed 2022-09-15 02:47 Tx date 2022-04-13 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,573,253 vol |
93,332 | |
Filed 2022-04-11 13:03 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-14 16:14 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-31 17:26 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+4,666,585 vol |
9,333,170 | |
Filed 2022-03-31 17:25 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
51 - Exercise of options
|
-4,666,585 vol |
0 | |
Filed 2022-03-31 17:23 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
$909,984
+4,666,585 vol $0.195 each |
4,666,585 | |
Filed 2022-03-31 17:21 Tx date 2021-11-25 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
50 - Grant of options
|
$876,354
+4,494,125 vol $0.195 each |
||
Filed 2022-03-31 13:39 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Options Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-14 16:14 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,666,585 | ||
Filed 2022-03-14 14:39 Tx date 2020-04-30 |
$MYCO
Mydecine Innovations Group Inc. |
Roscow, Robert Fletcher
5 - Senior Officer of Issuer
Holder: RFR Consulting, LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,700,000 |